A novel SNP-based approach for non-invasive prenatal paternity testing using multiplex PCR targeted capture sequencing

Abstract

Objective: To enhance the safety, simplicity, and efficacy of non-invasive prenatal paternity testing, we developed a method based on multiplex PCR targeted capture sequencing technology utilizing single nucleotide polymorphisms (SNPs) as genetic markers.

Method: We screened 627 SNPs from public databases and literature based on specific criteria and population genetic data from 100 unrelated individuals. A total of 15 peripheral blood samples were collected from pregnant women and the suspected father. Paternal alleles were detected and analyzed in the plasma cell-free DNA (cfDNA) of pregnant women, fetal SNP genotypes were obtained, and the combined paternity index (CPI) was calculated for paternity testing.

Results: Biological fathers were accurately determined in all cases, with CPI values ranging from 1.05 × 10¹⁴ to 2.03 × 10³⁴, consistent with results obtained using polymerase chain reaction-capillary electrophoresis (PCR-CE) with short tandem repeats. Significant differences in CPI between unrelated males and biological fathers allowed for straightforward exclusion. Even cfDNA from maternal plasma as early as five gestational weeks enabled accurate paternity determination.

Conclusion: This novel approach demonstrates significant improvements by reducing the number of SNPs, streamlining the research procedure, and lowering costs, yielding substantial advancements in non-invasive prenatal paternity testing.

Keywords

Forensic genetics / next-generation sequencing (NGS) / single nucleotide polymorphisms (SNPs) / non-invasive prenatal paternity testing (NIPPT)

References

[1] Van den Veyver IB, Beaudet AL. Comparative genomic hybridization and prenatal diagnosis.Curr Opin Obstet Gynecol2006;18:185-91

[2] StephensonJN.Pregnancy testing and counseling.Pediatr Clin North Am1989;36:681-96

[3] LoYMD,ChamberlainPF.Presence of fetal DNA in maternal plasma and serum.Lancet1997;350:485-7

[4] LoYMD.Fetal DNA in maternal plasma.Ann N Y Acad Sci2000;906:141-7

[5] AlberryM,JonesM.Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.Prenat Diagn2007;27:415-8

[6] RongY,JiangX.Multiplex PCR for 17 Y-chromosome specific short tandem repeats (STR) to enhance the reliability of fetal sex determination in maternal plasma.Int J Mol Sci2012;13:5972-81 PMCID:PMC3382763

[7] ZhangS,ZhangM.Non-invasive prenatal paternity testing using cell-free fetal DNA from maternal plasma: DNA isolation and genetic marker studies.Leg Med2018;32:98-103

[8] ChristiansenSL,BørstingC.Non-invasive prenatal paternity testing using a standard forensic genetic massively parallel sequencing assay for amplification of human identification SNPs.Int J Legal Med2019;133:1361-8

[9] HuJ,JinP,SunY.Prenatal diagnosis of trisomy 8 mosaicism, initially identified by cffDNA screening.Mol Cytogenet2022;15:39 PMCID:PMC9434846

[10] JuvetLK,Stoinska-SchneiderA.Non-invasive prenatal test (NIPT) for identification of trisomy 21, 18 and 13: report from the Norwegian Institute of Public Health No. 2016-18. 2016.

[11] ButlerJM.Genetics and genomics of core short tandem repeat loci used in human identity testing.J Forensic Sci2006;51:253-65

[12] WagnerJ,MarjanovićD.Non-invasive prenatal paternity testing from maternal blood.Int J Legal Med2009;123:75-9

[13] ZhangR,WangL.Set of 15 SNP-SNP markers for detection of unbalanced degraded DNA mixtures and noninvasive prenatal paternity testing.Front Genet2021;12:800598 PMCID:PMC8866868

[14] ShenX,LiH.Noninvasive prenatal paternity testing with a combination of well-established SNP and STR markers using massively parallel sequencing.Genes2021;12:454 PMCID:PMC8004970

[15] ChangL,MiaoX,LiS.Development and comprehensive evaluation of a noninvasive prenatal paternity testing method through a scaled trial.Forensic Sci Int Genet2019;43:102158

[16] GillP.An assessment of the utility of single nucleotide polymorphisms (SNPs) for forensic purposes.Int J Legal Med2001;114:204-10

[17] MoriotA.Analysis of fetal DNA in maternal plasma with markers designed for forensic DNA mixture resolution.Genet Med2019;21:613-21

[18] OuX.Noninvasive prenatal paternity testing by target sequencing microhaps.Forensic Sci Int Genet2020;48:102338

[19] GiannicoR,AndriolettiV.NIPAT as non-invasive prenatal paternity testing using a panel of 861 SNVs.Genes2023;14:312 PMCID:PMC9957069

[20] ChenP,LiZ.A microhaplotypes panel for massively parallel sequencing analysis of DNA mixtures.Forensic Sci Int Genet2019;40:140-9

[21] ChiuRWK,LauTK,WongEMC.Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma.Clin Chem2001;47:1607-13

[22] ZhengH,ZhangJ.Development and validation of a novel SiFaSTR^TM 23-plex system.Electrophoresis2019;40:2644-54

[23] McKennaA,BanksE.The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.Genome Res2010;20:1297-303 PMCID:PMC2928508

[24] LiH.Fast and accurate short read alignment with Burrows-Wheeler transform.Bioinformatics2009;25:1754-60 PMCID:PMC2705234

[25] LiH,WysokerA.The sequence alignment/map format and SAMtools.Bioinformatics2009;25:2078-9 PMCID:PMC2723002

[26] BaurMP,GürtlerH.No fallacies in the formulation of the paternity index.Am J Hum Genet1986;39:528-36 PMCID:PMC1683973

[27] LoYMD,BaigentCN.Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction.Hum Genet1993;90:483-8

[28] ButlerJM.Recent developments in Y-short tandem repeat and Y-single nucleotide polymorphism analysis.Forensic Sci Rev2003;15:91-111

[29] XuH,MaLL.Informative priors on fetal fraction increase power of the noninvasive prenatal screen.Genet Med2018;20:817-24

[30] Zaki-DizajiM,KohandelGargari O,HeidaryZ.Maternal and fetal factors affecting cell-free fetal DNA (cffDNA) fraction: a systematic review.J Reprod Infertil2023;24:219-31 PMCID:PMC10757682

[31] BirchL,O'DonoghueK,FiskNM.Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation.Clin Chem2005;51:312-20

[32] MorayN,BorryP.Paternity testing under the cloak of recreational genetics.Eur J Hum Genet2017;25:768-70 PMCID:PMC5477360

[33] ToyaW.Ethical, legal and social issues in Japan on the determination of blood relationship via DNA testing.Asian Bioeth Rev2017;9:19-32 PMCID:PMC5585996

[34] TamJCW,TsangSY.Noninvasive prenatal paternity testing by means of SNP-based targeted sequencing.Prenat Diagn2020;40:497-506 PMCID:PMC7154534